TreeWAS – Variant ID: rs914189

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T42.4 Benzodiazepines	0.049	0.951	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.036	0.964	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.030	0.970	0.000
T42.1 Iminostilbenes	0.027	0.972	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.026	0.974	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.026	0.974	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.026	0.974	0.000
T42.3 Barbiturates	0.026	0.974	0.000
T42.2 Succinimides and oxazolidinediones	0.026	0.974	0.000
T42.0 Hydantoin derivatives	0.023	0.976	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.021	0.979	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.021	0.979	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.021	0.979	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.020	0.980	0.000
T40.4 Other synthetic narcotics	0.019	0.981	0.000
T40.6 Other and unspecified narcotics	0.018	0.982	0.000
T40.3 Methadone	0.017	0.983	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.016	0.984	0.000
T40.5 Cocaine	0.016	0.984	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.016	0.984	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.015	0.985	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.015	0.985	0.000
T40.8 Lysergide [LSD]	0.015	0.985	0.000
T40.7 Cannabis (derivatives)	0.015	0.985	0.000
T40.1 Heroin	0.015	0.985	0.000
T40.0 Opium	0.015	0.985	0.000
T50.7 Analeptics and opioid receptor antagonists	0.015	0.985	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.015	0.985	0.000
T50.5 Appetite depressants	0.015	0.985	0.000
T50.4 Drugs affecting uric acid metabolism	0.015	0.985	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.015	0.985	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.015	0.985	0.000
T50.1 Loop [high-ceiling] diuretics	0.015	0.985	0.000
T50.0 Mineralocorticoids and their antagonists	0.015	0.985	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.015	0.985	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.015	0.985	0.000
T50.8 Diagnostic agents	0.015	0.985	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.015	0.985	0.000
T40.2 Other opioids	0.014	0.986	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.013	0.987	0.000
T45.0 Antiallergic and antiemetic drugs	0.013	0.987	0.000
T36 Poisoning by systemic antibiotics	0.013	0.987	0.000
T48.5 Anti-common-cold drugs	0.013	0.987	0.000
T45.2 Vitamins, not elsewhere classified	0.012	0.987	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.012	0.988	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.012	0.988	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.012	0.988	0.000
T48.4 Expectorants	0.012	0.988	0.000
T48.3 Antitussives	0.012	0.988	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.012	0.988	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.012	0.988	0.000
T48.0 Oxytocic drugs	0.012	0.988	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.012	0.988	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.012	0.988	0.000
T45.8 Other primarily systemic and haematological agents	0.012	0.988	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.012	0.988	0.000
T45.6 Fibrinolysis-affecting drugs	0.012	0.988	0.000
T45.4 Iron and its compounds	0.012	0.988	0.000
T45.3 Enzymes, not elsewhere classified	0.012	0.988	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.012	0.988	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.011	0.989	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.989	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.011	0.989	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.011	0.989	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.011	0.989	0.000
T44.0 Anticholinesterase agents	0.011	0.989	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.011	0.989	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.011	0.989	0.000
T41.5 Therapeutic gases	0.011	0.989	0.000
T41.4 Anaesthetic, unspecified	0.011	0.989	0.000
T41.3 Local anaesthetics	0.011	0.989	0.000
T41.2 Other and unspecified general anaesthetics	0.011	0.989	0.000
T41.1 Intravenous anaesthetics	0.011	0.989	0.000
T41.0 Inhaled anaesthetics	0.011	0.989	0.000
T49.9 Topical agent, unspecified	0.011	0.989	0.000
T49.8 Other topical agents	0.011	0.989	0.000
T49.7 Dental drugs, topically applied	0.011	0.989	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.011	0.989	0.000
T49.5 Ophthalmological drugs and preparations	0.011	0.989	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.011	0.989	0.000
T49.3 Emollients, demulcents and protectants	0.011	0.989	0.000
T49.2 Local astringents and local detergents	0.011	0.989	0.000
T49.1 Antipruritics	0.011	0.989	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.011	0.989	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.011	0.989	0.000
T37.5 Antiviral drugs	0.011	0.989	0.000
T37.4 Anthelminthics	0.011	0.989	0.000
T37.3 Other antiprotozoal drugs	0.011	0.989	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.011	0.989	0.000
T37.1 Antimycobacterial drugs	0.011	0.989	0.000
T37.0 Sulphonamides	0.011	0.989	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.011	0.989	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.011	0.989	0.000
T45.5 Anticoagulants	0.011	0.989	0.000
T36.3 Macrolides	0.010	0.990	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.010	0.990	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.010	0.990	0.000
T47.7 Emetics	0.010	0.990	0.000
T47.6 Antidiarrhoeal drugs	0.010	0.990	0.000
T47.5 Digestants	0.010	0.990	0.000
T47.4 Other laxatives	0.010	0.990	0.000
T47.3 Saline and osmotic laxatives	0.010	0.990	0.000
T47.2 Stimulant laxatives	0.010	0.990	0.000
T47.0 Histamine H(2)-receptor antagonists	0.010	0.990	0.000
T36.9 Systemic antibiotic, unspecified	0.009	0.990	0.000
T36.8 Other systemic antibiotics	0.009	0.990	0.000
T36.7 Antifungal antibiotics, systemically used	0.009	0.990	0.000
T36.6 Rifamycins	0.009	0.990	0.000
T36.5 Aminoglycosides	0.009	0.990	0.000
T36.4 Tetracyclines	0.009	0.990	0.000
T36.2 Chloramphenicol group	0.009	0.990	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.009	0.990	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.009	0.991	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.008	0.991	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.008	0.991	0.000
T46.7 Peripheral vasodilators	0.008	0.991	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.008	0.991	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.008	0.991	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.008	0.991	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.008	0.992	0.000
T38.9 Other and unspecified hormone antagonists	0.008	0.992	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.008	0.992	0.000
T38.7 Androgens and anabolic congeners	0.008	0.992	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.008	0.992	0.000
T38.5 Other oestrogens and progestogens	0.008	0.992	0.000
T38.4 Oral contraceptives	0.008	0.992	0.000
T38.2 Antithyroid drugs	0.008	0.992	0.000
T38.0 Glucocorticoids and synthetic analogues	0.008	0.992	0.000
T38.1 Thyroid hormones and substitutes	0.008	0.992	0.000
I25.2 Old myocardial infarction	0.000	0.992	0.008
M19.99 Arthrosis, unspecified (Site unspecified)	0.008	0.992	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.008	0.992	0.000
A49.0 Staphylococcal infection, unspecified	0.000	0.992	0.008
T46.1 Calcium-channel blockers	0.007	0.993	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.007	0.993	0.000
T36.0 Penicillins	0.006	0.993	0.001
A41.1 Septicaemia due to other specified staphylococcus	0.000	0.994	0.006
A41.5 Septicaemia due to other Gram-negative organisms	0.000	0.994	0.006
A41 Other septicaemia	0.000	0.995	0.005
A49 Bacterial infection of unspecified site	0.000	0.995	0.005
A41.2 Septicaemia due to unspecified staphylococcus	0.000	0.995	0.005
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.995	0.001
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.004	0.996	0.000
A49.2 Haemophilus influenzae infection, unspecified	0.000	0.996	0.004
D17.7 Benign lipomatous neoplasm of other sites	0.000	0.996	0.004
A30-A49 Other bacterial diseases	0.000	0.996	0.004
A41.4 Septicaemia due to anaerobes	0.000	0.996	0.004
A41.3 Septicaemia due to Haemophilus influenzae	0.000	0.996	0.004
A49.9 Bacterial infection, unspecified	0.000	0.996	0.004
A41.0 Septicaemia due to Staphylococcus aureus	0.000	0.996	0.004
I22.9 Subsequent myocardial infarction of unspecified site	0.004	0.996	0.000
A49.3 Mycoplasma infection, unspecified	0.000	0.996	0.004
Z93.0 Tracheostomy status	0.000	0.996	0.004
M54.22 Cervicalgia (Cervical region)	0.004	0.996	0.000
M79.65 Pain in limb (Pelvic region and thigh)	0.000	0.997	0.003
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
M25.46 Effusion of joint (Lower leg)	0.003	0.997	0.000
A46 Erysipelas	0.000	0.997	0.003
T39.4 Antirheumatics, not elsewhere classified	0.003	0.997	0.000
T39.2 Pyrazolone derivatives	0.003	0.997	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
R44.1 Visual hallucinations	0.003	0.997	0.000
A31 Infection due to other mycobacteria	0.000	0.997	0.003
A49.8 Other bacterial infections of unspecified site	0.000	0.997	0.003
T84.5 Infection and inflammatory reaction due to internal joint prosthesis	0.003	0.997	0.000
A44 Bartonellosis	0.000	0.997	0.003
A43 Nocardiosis	0.000	0.997	0.003
A42 Actinomycosis	0.000	0.997	0.003
A39 Meningococcal infection	0.000	0.997	0.003
A37 Whooping cough	0.000	0.997	0.003
A36 Diphtheria	0.000	0.997	0.003
A32 Listeriosis	0.000	0.997	0.003
A30 Leprosy [Hansen's disease]	0.000	0.997	0.003
A38 Scarlet fever	0.000	0.997	0.003
A35 Other tetanus	0.000	0.997	0.003
A34 Obstetrical tetanus	0.000	0.997	0.003
A33 Tetanus neonatorum	0.000	0.997	0.003
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
H54.7 Unspecified visual loss	0.003	0.997	0.000
X62.9 Unspecified place	0.003	0.997	0.000
M24.41 Recurrent dislocation and subluxation of joint (Shoulder region)	0.000	0.997	0.003
T43.6 Psychostimulants with abuse potential	0.003	0.997	0.000
A48 Other bacterial diseases, not elsewhere classified	0.000	0.997	0.003
F52.2 Failure of genital response	0.003	0.997	0.000
D04.3 Skin of other and unspecified parts of face	0.003	0.997	0.000
A39.0 Meningococcal meningitis	0.000	0.997	0.003
A31.0 Pulmonary mycobacterial infection	0.000	0.997	0.003
A49.1 Streptococcal infection, unspecified	0.000	0.997	0.002
C71.1 Frontal lobe	0.000	0.997	0.003
A41.8 Other specified septicaemia	0.000	0.997	0.002
I22.8 Subsequent myocardial infarction of other sites	0.003	0.997	0.000
A31.8 Other mycobacterial infections	0.000	0.997	0.002
A31.1 Cutaneous mycobacterial infection	0.000	0.997	0.002
A30.9 Leprosy, unspecified	0.000	0.997	0.002
A30.8 Other forms of leprosy	0.000	0.997	0.002
A30.5 Lepromatous leprosy	0.000	0.997	0.002
A30.4 Borderline lepromatous leprosy	0.000	0.997	0.002
A30.3 Borderline leprosy	0.000	0.997	0.002
A30.2 Borderline tuberculoid leprosy	0.000	0.997	0.002
A30.1 Tuberculoid leprosy	0.000	0.997	0.002
A30.0 Indeterminate leprosy	0.000	0.997	0.002
A32.9 Listeriosis, unspecified	0.000	0.997	0.002
A32.8 Other forms of listeriosis	0.000	0.997	0.002
A32.7 Listerial septicaemia	0.000	0.997	0.002
A32.1 Listerial meningitis and meningoencephalitis	0.000	0.997	0.002
A32.0 Cutaneous listeriosis	0.000	0.997	0.002
A36.9 Diphtheria, unspecified	0.000	0.997	0.002
A36.8 Other diphtheria	0.000	0.997	0.002
A36.3 Cutaneous diphtheria	0.000	0.997	0.002
A36.2 Laryngeal diphtheria	0.000	0.997	0.002
A36.1 Nasopharyngeal diphtheria	0.000	0.997	0.002
A36.0 Pharyngeal diphtheria	0.000	0.997	0.002
A37.9 Whooping cough, unspecified	0.000	0.997	0.002
A37.8 Whooping cough due to other Bordetella species	0.000	0.997	0.002
A37.1 Whooping cough due to Bordetella parapertussis	0.000	0.997	0.002
A37.0 Whooping cough due to Bordetella pertussis	0.000	0.997	0.002
A39.9 Meningococcal infection, unspecified	0.000	0.997	0.002
A39.8 Other meningococcal infections	0.000	0.997	0.002
A39.5 Meningococcal heart disease	0.000	0.997	0.002
A39.3 Chronic meningococcaemia	0.000	0.997	0.002
A39.2 Acute meningococcaemia	0.000	0.997	0.002
A39.1 Waterhouse-Friderichsen syndrome	0.000	0.997	0.002
A42.9 Actinomycosis, unspecified	0.000	0.997	0.002
A42.8 Other forms of actinomycosis	0.000	0.997	0.002
A42.7 Actinomycotic septicaemia	0.000	0.997	0.002
A42.2 Cervicofacial actinomycosis	0.000	0.997	0.002
A42.1 Abdominal actinomycosis	0.000	0.997	0.002
A42.0 Pulmonary actinomycosis	0.000	0.997	0.002
A43.9 Nocardiosis, unspecified	0.000	0.997	0.002
A43.8 Other forms of nocardiosis	0.000	0.997	0.002
A43.1 Cutaneous nocardiosis	0.000	0.997	0.002
A43.0 Pulmonary nocardiosis	0.000	0.997	0.002
A44.9 Bartonellosis, unspecified	0.000	0.997	0.002
A44.8 Other forms of bartonellosis	0.000	0.997	0.002
A44.1 Cutaneous and mucocutaneous bartonellosis	0.000	0.997	0.002
A44.0 Systemic bartonellosis	0.000	0.997	0.002
G90.2 Horner's syndrome	0.000	0.997	0.003
H44.2 Degenerative myopia	0.003	0.997	0.000
M25.4 Effusion of joint	0.003	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.002	0.997	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.002	0.997	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.997	0.000
I22 Subsequent myocardial infarction	0.003	0.997	0.000
M25.42 Effusion of joint (Upper arm)	0.002	0.998	0.000
H54.0 Blindness, both eyes	0.002	0.998	0.000
A31.9 Mycobacterial infection, unspecified	0.000	0.998	0.002
I22.0 Subsequent myocardial infarction of anterior wall	0.002	0.998	0.000
M25.41 Effusion of joint (Shoulder region)	0.002	0.998	0.000
A48.4 Brazilian purpuric fever	0.000	0.998	0.002
A48.3 Toxic shock syndrome	0.000	0.998	0.002
A48.2 Nonpneumonic Legionnaires' disease [Pontiac fever]	0.000	0.998	0.002
A48.0 Gas gangrene	0.000	0.998	0.002
R44.3 Hallucinations, unspecified	0.002	0.998	0.000
R44 Other symptoms and signs involving general sensations and perceptions	0.002	0.998	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
M25.43 Effusion of joint (Forearm)	0.002	0.998	0.000
Y45.1 Salicylates	0.002	0.998	0.000
A39.4 Meningococcaemia, unspecified	0.000	0.998	0.002
Y45.0 Opioids and related analgesics	0.002	0.998	0.000
M25.45 Effusion of joint (Pelvic region and thigh)	0.002	0.998	0.000
A48.8 Other specified bacterial diseases	0.000	0.998	0.002
G31.9 Degenerative disease of nervous system, unspecified	0.002	0.998	0.000
G90.9 Disorder of autonomic nervous system, unspecified	0.000	0.998	0.002
A40 Streptococcal septicaemia	0.000	0.998	0.002
Z63.5 Disruption of family by separation and divorce	0.002	0.998	0.000
S92.30 Fracture of metatarsal bone (closed)	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.002	0.998	0.000
H54 Blindness and low vision	0.002	0.998	0.000
R44.0 Auditory hallucinations	0.002	0.998	0.000
G90.0 Idiopathic peripheral autonomic neuropathy	0.000	0.998	0.002
M25.49 Effusion of joint (Site unspecified)	0.002	0.998	0.000
M25.48 Effusion of joint (Other)	0.002	0.998	0.000
M25.47 Effusion of joint (Ankle and foot)	0.002	0.998	0.000
A48.1 Legionnaires' disease	0.000	0.998	0.002
M25.44 Effusion of joint (Hand)	0.002	0.998	0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.002	0.998	0.000
M25.77 Osteophyte (Ankle and foot)	0.002	0.998	0.000
G90 Disorders of autonomic nervous system	0.000	0.998	0.002
H54.6 Unqualified visual loss, one eye	0.002	0.998	0.000
H54.5 Low vision, one eye	0.002	0.998	0.000
R44.8 Other and unspecified symptoms and signs involving general sensations and perceptions	0.002	0.998	0.000
G59.0 Diabetic mononeuropathy	0.002	0.998	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.002	0.998	0.000
R44.2 Other hallucinations	0.002	0.998	0.000
Z63.8 Other specified problems related to primary support group	0.002	0.998	0.000
Y45.4 Antirheumatics	0.002	0.998	0.000
A40.2 Septicaemia due to streptococcus, group D	0.000	0.998	0.002
M96.8 Other postprocedural musculoskeletal disorders	0.002	0.998	0.000
M43.06 Spondylolysis (Lumbar region)	0.002	0.998	0.000
A40.3 Septicaemia due to Streptococcus pneumoniae	0.000	0.998	0.002
H54.2 Low vision, both eyes	0.002	0.998	0.000
A04.5 Campylobacter enteritis	0.000	0.998	0.002
H54.3 Unqualified visual loss, both eyes	0.002	0.998	0.000
Z63 Other problems related to primary support group, including family circumstances	0.002	0.998	0.000
Z63.0 Problems in relationship with spouse or partner	0.002	0.998	0.000
Y45.8 Other analgesics and antipyretics	0.002	0.998	0.000
Z60.2 Living alone	0.002	0.998	0.000
D07.1 Vulva	0.002	0.998	0.000
A40.0 Septicaemia due to streptococcus, group A	0.000	0.998	0.002
M96.0 Pseudarthrosis after fusion or arthrodesis	0.002	0.998	0.000
X62.0 Home	0.002	0.998	0.000
X62.8 Other specified place	0.002	0.998	0.000
X62.7 Farm	0.002	0.998	0.000
X62.6 Industrial and construction area	0.002	0.998	0.000
X62.5 Trade and service area	0.002	0.998	0.000
X62.4 Street and highway	0.002	0.998	0.000
X62.3 Sports and athletics area	0.002	0.998	0.000
X62.2 School, other institution and public administrative area	0.002	0.998	0.000
X62.1 Residential institution	0.002	0.998	0.000
M25.40 Effusion of joint (Multiple sites)	0.002	0.998	0.000
A40.1 Septicaemia due to streptococcus, group B	0.000	0.998	0.002
H50.0 Convergent concomitant strabismus	0.002	0.998	0.000
X63.0 Home	0.002	0.998	0.000
A40.9 Streptococcal septicaemia, unspecified	0.000	0.998	0.002
G90.4 Autonomic dysreflexia	0.000	0.998	0.002
G90.1 Familial dysautonomia [Riley-Day]	0.000	0.998	0.002
H54.1 Blindness, one eye, low vision, other eye	0.002	0.998	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.002	0.998	0.000
F52 Sexual dysfunction, not caused by organic disorder or disease	0.002	0.998	0.000
C09.9 Tonsil, unspecified	0.002	0.998	0.000
M96.9 Postprocedural musculoskeletal disorder, unspecified	0.002	0.998	0.000
I37.1 Pulmonary valve insufficiency	0.002	0.998	0.000
M96 Postprocedural musculoskeletal disorders, not elsewhere classified	0.002	0.998	0.000
G90.8 Other disorders of autonomic nervous system	0.000	0.998	0.002
H20.9 Iridocyclitis, unspecified	0.002	0.998	0.000
G99.0 Autonomic neuropathy in endocrine and metabolic diseases	0.000	0.998	0.002
L50.9 Urticaria, unspecified	0.000	0.998	0.002
T91.8 Sequelae of other specified injuries of neck and trunk	0.002	0.998	0.000
Y45.5 4-Aminophenol derivatives	0.001	0.998	0.000
Z63.4 Disappearance and death of family member	0.002	0.998	0.000
Z63.9 Problem related to primary support group, unspecified	0.001	0.998	0.000
Z63.3 Absence of family member	0.001	0.998	0.000
Z63.2 Inadequate family support	0.001	0.998	0.000
Z63.1 Problems in relationship with parents and in-laws	0.001	0.998	0.000
M43.09 Spondylolysis (Site unspecified)	0.001	0.998	0.000
N70.1 Chronic salpingitis and oophoritis	0.000	0.998	0.002
Q79.6 Ehlers-Danlos syndrome	0.002	0.998	0.000
H50.4 Other and unspecified heterotropia	0.002	0.998	0.000
M43.0 Spondylolysis	0.002	0.998	0.000
X62.09 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified: Home: During unspecified activity	0.001	0.998	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.002	0.998	0.000
J00 Acute nasopharyngitis [common cold]	0.002	0.998	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.001	0.998	0.000
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease	0.001	0.998	0.000
F52.8 Other sexual dysfunction, not caused by organic disorder or disease	0.001	0.998	0.000
F52.7 Excessive sexual drive	0.001	0.998	0.000
F52.6 Nonorganic dyspareunia	0.001	0.998	0.000
F52.5 Nonorganic vaginismus	0.001	0.998	0.000
F52.4 Premature ejaculation	0.001	0.998	0.000
F52.3 Orgasmic dysfunction	0.001	0.998	0.000
F52.1 Sexual aversion and lack of sexual enjoyment	0.001	0.998	0.000
F52.0 Lack or loss of sexual desire	0.001	0.998	0.000
H54.9 Unspecified visual impairment (binocular)	0.001	0.998	0.000
I22.1 Subsequent myocardial infarction of inferior wall	0.001	0.998	0.000
J03.9 Acute tonsillitis, unspecified	0.002	0.998	0.000
T17.2 Foreign body in pharynx	0.000	0.998	0.001
D41.0 Kidney	0.001	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.998	0.000
M96.6 Fracture of bone following insertion of orthopaedic implant, joint prosthesis or bone plate	0.001	0.999	0.000
M96.5 Postradiation scoliosis	0.001	0.999	0.000
M96.4 Postsurgical lordosis	0.001	0.999	0.000
M96.3 Postlaminectomy kyphosis	0.001	0.999	0.000
M96.2 Postradiation kyphosis	0.001	0.999	0.000
A40.8 Other streptococcal septicaemia	0.000	0.999	0.001
H04.2 Epiphora	0.001	0.999	0.000
H47.3 Other disorders of optic disk	0.001	0.999	0.000
M96.1 Postlaminectomy syndrome, not elsewhere classified	0.001	0.999	0.000
T17.9 Foreign body in respiratory tract, part unspecified	0.000	0.999	0.001
T39.0 Salicylates	0.001	0.999	0.000
Z63.6 Dependent relative needing care at home	0.001	0.999	0.000
S62.00 Fracture of navicular [scaphoid] bone of hand (closed)	0.000	0.999	0.001
T17.5 Foreign body in bronchus	0.000	0.999	0.001
H49.0 Third [oculomotor] nerve palsy	0.000	0.999	0.001
H54.4 Blindness, one eye	0.001	0.999	0.000
J01.9 Acute sinusitis, unspecified	0.001	0.999	0.000
J01.0 Acute maxillary sinusitis	0.001	0.999	0.000
L89.2 Stage III decubitus ulcer	0.001	0.999	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.001	0.999	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.001	0.999	0.000
R93.8 Abnormal findings on diagnostic imaging of other specified body structures	0.001	0.999	0.000
C44.6 Skin of upper limb, including shoulder	0.001	0.999	0.000
G90.3 Multisystem degeneration	0.000	0.999	0.001
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.000	0.999	0.001
M43.08 Spondylolysis (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M43.07 Spondylolysis (Lumbosacral region)	0.001	0.999	0.000
M43.05 Spondylolysis (Thoracolumbar region)	0.001	0.999	0.000
M43.04 Spondylolysis (Thoracic region)	0.001	0.999	0.000
M43.03 Spondylolysis (Cervicothoracic region)	0.001	0.999	0.000
M43.02 Spondylolysis (Cervical region)	0.001	0.999	0.000
M43.01 Spondylolysis (Occipito-atlanto-axial region)	0.001	0.999	0.000
M43.00 Spondylolysis (Multiple sites in spine)	0.001	0.999	0.000
X63.9 Unspecified place	0.001	0.999	0.000
X63.8 Other specified place	0.001	0.999	0.000
X63.7 Farm	0.001	0.999	0.000
X63.6 Industrial and construction area	0.001	0.999	0.000
X63.5 Trade and service area	0.001	0.999	0.000
X63.4 Street and highway	0.001	0.999	0.000
X63.3 Sports and athletics area	0.001	0.999	0.000
X63.2 School, other institution and public administrative area	0.001	0.999	0.000
X63.1 Residential institution	0.001	0.999	0.000
X60-X84 Intentional self-harm	0.001	0.999	0.000
I97.8 Other postprocedural disorders of circulatory system, not elsewhere classified	0.000	0.999	0.001
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.001	0.999	0.000
F32.2 Severe depressive episode without psychotic symptoms	0.001	0.999	0.000
J01.2 Acute ethmoidal sinusitis	0.001	0.999	0.000
T91.3 Sequelae of injury of spinal cord	0.001	0.999	0.000
T91.1 Sequelae of fracture of spine	0.001	0.999	0.000
Y44.2 Anticoagulants	0.000	0.999	0.001
J01 Acute sinusitis	0.001	0.999	0.000
M23.29 Derangement of meniscus due to old tear or injury (Unspecified ligament or Unspecified meniscus)	0.001	0.999	0.000
M96.65 Fracture of pelvis following insertion of orthopedic implant, joint prosthesis, or bone plate (Fx pelvis following insrt ortho implnt/prosth/bone plt)	0.001	0.999	0.000
M96.63 Fracture of radius or ulna following insertion of orthopedic implant, joint prosthesis, or bone plate	0.001	0.999	0.000
U81.0 Vancomycin resistant agent	0.000	0.999	0.001
Z60 Problems related to social environment	0.001	0.999	0.000
D16.4 Bones of skull and face	0.001	0.999	0.000
K35.3 Acute appendicitis with localized peritonitis	0.001	0.999	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.000	0.999	0.001
N42.1 Congestion and haemorrhage of prostate	0.001	0.999	0.000
X60.8 Other specified place	0.001	0.999	0.000
X60.2 School, other institution and public administrative area	0.001	0.999	0.000
X67.0 Home	0.001	0.999	0.000
Z63.7 Other stressful life events affecting family and household	0.001	0.999	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.999	0.001
I30.9 Acute pericarditis, unspecified	0.001	0.999	0.000
M54.2 Cervicalgia	0.001	0.999	0.000
Q78.0 Osteogenesis imperfecta	0.001	0.999	0.000
T17 Foreign body in respiratory tract	0.000	0.999	0.001
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.001	0.999	0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.000	0.999	0.001
Z65.8 Other specified problems related to psychosocial circumstances	0.001	0.999	0.000
X65 Intentional self-poisoning by and exposure to alcohol	0.001	0.999	0.000
X63.99 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system; Unspecified place ;During unspecified activity	0.001	0.999	0.000
S92.3 Fracture of metatarsal bone	0.000	0.999	0.001
X60.9 Unspecified place	0.001	0.999	0.000
X60.0 Home	0.001	0.999	0.000
X60.7 Farm	0.001	0.999	0.000
X60.6 Industrial and construction area	0.001	0.999	0.000
X60.5 Trade and service area	0.001	0.999	0.000
X60.4 Street and highway	0.001	0.999	0.000
X60.3 Sports and athletics area	0.001	0.999	0.000
X60.1 Residential institution	0.001	0.999	0.000
Z48.9 Surgical follow-up care, unspecified	0.001	0.999	0.000
Q79 Congenital malformations of musculoskeletal system, not elsewhere classified	0.001	0.999	0.000
X84 Intentional self-harm by unspecified means	0.001	0.999	0.000
X83 Intentional self-harm by other specified means	0.001	0.999	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.001	0.999	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.001	0.999	0.000
X80 Intentional self-harm by jumping from a high place	0.001	0.999	0.000
X79 Intentional self-harm by blunt object	0.001	0.999	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.001	0.999	0.000
X76 Intentional self-harm by smoke, fire and flames	0.001	0.999	0.000
X75 Intentional self-harm by explosive material	0.001	0.999	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.001	0.999	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.001	0.999	0.000
X72 Intentional self-harm by handgun discharge	0.001	0.999	0.000
X71 Intentional self-harm by drowning and submersion	0.001	0.999	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.001	0.999	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.001	0.999	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.001	0.999	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.001	0.999	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
I15.9 Seconday hypertension, unspecified	0.001	0.999	0.000
J01.8 Other acute sinusitis	0.001	0.999	0.000
J01.4 Acute pansinusitis	0.001	0.999	0.000
J01.3 Acute sphenoidal sinusitis	0.001	0.999	0.000
J01.1 Acute frontal sinusitis	0.001	0.999	0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.001	0.999	0.000
Z60.5 Target of perceived adverse discrimination and persecution	0.001	0.999	0.000
Z60.4 Social exclusion and rejection	0.001	0.999	0.000
Z60.3 Acculturation difficulty	0.001	0.999	0.000
Z60.1 Atypical parenting situation	0.001	0.999	0.000
Z60.0 Problems of adjustment to life-cycle transitions	0.001	0.999	0.000
G25.3 Myoclonus	0.001	0.999	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.999	0.001
M54.28 Cervicalgia-Sacral/sacrococ	0.001	0.999	0.000
M54.27 Cervicalgia-Lumbosacral	0.001	0.999	0.000
M54.26 Cervicalgia-Lumbar	0.001	0.999	0.000
M54.25 Cervicalgia-Thoracolumbar	0.001	0.999	0.000
M54.24 Cervicalgia-Thoracic	0.001	0.999	0.000
M54.23 Cervicalgia (Cervicothoracic region)	0.001	0.999	0.000
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.001	0.999	0.000
M54.20 Cervicalgia-Mult site	0.001	0.999	0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.000	0.999	0.001
J86.0 Pyothorax with fistula	0.001	0.999	0.000
T17.4 Foreign body in trachea	0.000	0.999	0.001
T17.1 Foreign body in nostril	0.000	0.999	0.001
T17.0 Foreign body in nasal sinus	0.000	0.999	0.001
U89.8 Agent resistant to other single specified antibiotic	0.000	0.999	0.001
X65.8 Other specified place	0.001	0.999	0.000
X67.8 Other specified place	0.001	0.999	0.000
X67.7 Farm	0.001	0.999	0.000
X67.6 Industrial and construction area	0.001	0.999	0.000
X67.5 Trade and service area	0.001	0.999	0.000
X67.4 Street and highway	0.001	0.999	0.000
X67.3 Sports and athletics area	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations